 |
| Ligand ID: CTX Drugbank ID: DB00675(Tamoxifen) Indication:Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men and ductal carcinoma in Situ. |
| DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
|---|---|---|---|---|---|---|---|---|---|---|
 Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 258SER A 254VAL A 212LEU A 262LEU A 220 | 1.75A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 159GLY A 29VAL A 68SER A 81LEU A 32 | 1.62A | 14.07 | NoneNoneNoneK1Y A 404 (-3.2A)None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 271SER A 267LEU A 272LEU A 282LEU A 205 | 1.74A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 159GLY A 146VAL A 20LEU A 27LEU A 32 | 1.73A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 23SER A 62LEU A 67LEU A 57LEU A 89 | 1.53A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.39A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 159GLY A 29VAL A 68SER A 81LEU A 32 | 1.67A | 14.07 | NoneNoneNoneK1Y A 404 (-3.2A)None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 268SER A 267LEU A 272LEU A 250HIS A 246 | 1.65A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 271SER A 267LEU A 272LEU A 282LEU A 205 | 1.76A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.40A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 268SER A 267LEU A 272LEU A 250HIS A 246 | 1.70A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 20LEU A 87LEU A 89LEU A 57LEU A 27 | 1.73A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 20LEU A 87LEU A 89LEU A 57LEU A 27 | 1.78A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 159GLY A 146VAL A 20LEU A 27LEU A 32 | 1.73A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 23SER A 62LEU A 67LEU A 57LEU A 89 | 1.56A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 140GLY A 146VAL A 13LEU A 177LEU A 30 | 1.64A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 140GLY A 146VAL A 13LEU A 177LEU A 30 | 1.66A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 159GLY A 29VAL A 68LEU A 32LEU A 75 | 1.79A | 14.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 5 / 12 | ALA C1190SER B 937SER C 943LEU C1186LEU B 945 | 1.30A | 14.31 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.32A | 19.44 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.32A | 19.44 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23SER A 62LEU A 67LEU A 57LEU A 89 | 1.51A | 19.44 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.37A | 19.85 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.30A | 19.85 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.38A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 23VAL C 20SER C 62LEU C 57LEU C 89 | 1.34A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 23VAL C 20SER C 62LEU C 57LEU C 89 | 1.42A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY B 23VAL B 20SER B 62LEU B 57LEU B 89 | 1.35A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 6 / 12 | GLY D 23VAL D 20SER D 62LEU D 67LEU D 57LEU D 89 | 1.45A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY B 23VAL B 20SER B 62LEU B 57LEU B 89 | 1.45A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY D 23SER D 62LEU D 67LEU D 57LEU D 89 | 1.36A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY D 23VAL D 20SER D 62LEU D 57LEU D 89 | 1.38A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.48A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.41A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.42A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23SER A 62LEU A 67LEU A 57LEU A 89 | 1.53A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | LEU C 162GLY C 165LEU C 168PRO B 163 | 1.29A | 14.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 7 | LEU C 162GLY C 165LEU C 168PRO B 163 | 1.27A | 14.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 59PRO D 121ILE D 106LEU C 56 | 1.39A | 9.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 469PRO A 461ILE A 632LEU A 630 | 1.68A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.59A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 470PRO A 296ILE A 307LEU A 308 | 1.66A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 470PRO A 296ILE A 307LEU A 308 | 1.56A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | PRO A 378MET A 380LEU A 673PRO B 121 | 1.30A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 673MET B 129 | 1.72A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | SER C 15SER C 54LEU C 59MET C 52LEU D 95 | 1.50A | 9.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ALA A 375SER A 363LEU B 91LEU B 95LEU A 371 | 1.50A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 368VAL A 495SER A 501LEU A 498LEU A 372 | 1.48A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 883PRO A 868ILE A 837LEU A 838 | 1.78A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.56A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | PRO A 243MET A 242GLY A 179LEU A 131 | 1.60A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | PRO A 243MET A 242LEU A 247LEU A 131 | 1.75A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m71 | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE A 440LEU C 55SER C 54MET C 52LEU D 95 | 1.49A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | MET A 380LEU A 401LEU A 673PRO B 121 | 1.15A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 6 / 12 | PHE D 92VAL C 22LEU C 55LEU C 14LEU C 60LEU C 28 | 1.68A | 18.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6m71 | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE A 440LEU C 55SER C 54MET C 52LEU D 95 | 1.41A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m71 | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.32A | 18.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m71 | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | GLY A 841GLY A 839LEU A 437SER C 4LEU C 40 | 1.36A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6m71 | NSP8 (SARS-CoV-2) | 4 / 4 | LEU B 98PRO B 116ILE B 107LEU B 103 | 1.70A | 18.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m71 | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.44A | 18.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 59MET C 52LEU D 95 | 1.50A | 9.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 17LEU D 98LEU C 60 | 1.23A | 9.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 10LEU C 56LEU C 14LEU D 91 | 1.53A | 9.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 59MET C 52LEU D 95 | 1.45A | 9.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m71 | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | GLY A 841GLY A 839LEU A 437SER C 4LEU C 40 | 1.25A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6m71 | NSP8 (SARS-CoV-2) | 4 / 4 | LEU B 98PRO B 116ILE B 107LEU B 103 | 1.72A | 18.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6m71 | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ALA A 443LEU C 14SER C 10LEU C 17LEU D 91 | 1.39A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 17LEU D 98LEU C 60 | 1.16A | 9.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6m71 | NSP12NSP7 (SARS-CoV-2) | 6 / 12 | ALA A 423GLY A 841GLY A 839LEU A 437SER C 4LEU C 40 | 1.43A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 59MET C 52LEU D 95 | 1.35A | 9.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.61A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6m71 | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | ALA A 443SER C 25LEU C 14SER C 15LEU C 20 | 1.52A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 59PRO D 121ILE D 106LEU C 56 | 1.31A | 9.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 469PRO A 461ILE A 632LEU A 630 | 1.58A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 883PRO A 868ILE A 837LEU A 838 | 1.72A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 6 / 12 | PHE D 92VAL C 22LEU C 55LEU C 14LEU C 60LEU C 28 | 1.66A | 18.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | LEU C 387PRO C 412ILE C 434LEU C 513 | 1.67A | 17.76 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | PRO B 807LEU B 878GLY B 880LEU B 806 | 1.43A | 17.76 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 27GLY A 85LEU A 88LEU A 53HIS A 94 | 1.62A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.75A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.75A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | PRO B 125GLY B 85LEU B 53PRO B 32 | 1.77A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | PRO B 125GLY B 85LEU B 53PRO B 32 | 1.78A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | LEU B 533PRO B 521ILE B 584LEU B 585 | 1.71A | 17.87 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | PRO A 807LEU A 878GLY A 880LEU A 806 | 1.43A | 17.87 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | LEU C 533PRO C 521ILE C 584LEU C 585 | 1.67A | 17.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | PRO C 521LEU C 518GLY C 545PRO C 330 | 1.45A | 17.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | PRO A 807LEU A 878GLY A 880LEU A 806 | 1.42A | 17.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE B 92GLY B 103LEU B 117LEU B 118LEU B 110 | 1.44A | 17.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 4 / 8 | LEU C 161GLY C 71LEU C 56PRO C 168 | 1.26A | 13.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 38GLY A 79GLY A 78SER A 139LEU A 108 | 1.28A | 15.98 | APR A 201 (-3.4A)NoneNoneNoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 12 | PHE C 429GLY C 381LEU C 387LEU C 390LEU C 513 | 1.77A | 14.42 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w4b | NSP9 (SARS-CoV-2) | 5 / 12 | ALA B 44LEU B 107SER B 106LEU B 113LEU A 10 | 1.41A | 12.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6w4h | NSP16 (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.63A | 19.52 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6963GLY A6962VAL A7057LEU A7078LEU A7050 | 1.67A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.61A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6963GLY A6962LEU A7010LEU A7073LEU A6855 | 1.67A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | TRP A7029PRO A6810MET A6809LEU A6812 | 1.78A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6962GLY A6963VAL A6965LEU A6857LEU A6924 | 1.76A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6963GLY A6962LEU A6961LEU A7073LEU A6981 | 1.71A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6963GLY A6962LEU A7010LEU A7073LEU A6855 | 1.67A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6890VAL A6865LEU A6893LEU A7052LEU A6924 | 1.63A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6890VAL A6865LEU A6893LEU A7052LEU A6924 | 1.60A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6963GLY A6962LEU A7073SER A7071LEU A7078 | 1.79A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | ALA A6986GLY A6963GLY A6962SER A7071LEU A6961 | 1.77A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6962GLY A6963VAL A6865LEU A6855LEU A6887 | 1.77A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6962GLY A6963VAL A6965LEU A6857LEU A6924 | 1.75A | 16.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.38A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.47A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | SER B 139VAL B 144SER B 166LEU B 160LEU B 12 | 1.76A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | PHE B 116GLY B 78VAL B 41LEU B 93LEU B 43 | 1.77A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127SER B 128LEU B 75HIS B 94 | 1.35A | NoneNoneMES B 201 ( 4.5A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 47GLY B 51VAL B 24LEU B 43LEU B 88 | 1.78A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | SER A 139VAL A 144SER A 166LEU A 160LEU A 12 | 1.62A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 116GLY A 78VAL A 41LEU A 93LEU A 43 | 1.78A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.75A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 116GLY A 78VAL A 41LEU A 93LEU A 43 | 1.74A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA B 38GLY B 79GLY B 78LEU B 127SER B 139 | 1.70A | 15.80 | MES B 201 ( 3.4A)NoneNoneNoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | SER B 139VAL B 144SER B 166LEU B 160LEU B 12 | 1.65A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA B 39GLY B 79GLY B 78LEU B 108LEU B 127 | 1.67A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.76A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA B 27GLY B 85LEU B 88LEU B 53HIS B 94 | 1.69A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.39A | AMP A 201 ( 3.7A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | PRO B 125GLY B 85LEU B 53PRO B 32 | 1.78A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 39GLY A 79GLY A 78LEU A 108LEU A 127 | 1.64A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.36A | AMP A 201 ( 3.7A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 8LEU A 169SER A 166LEU A 10LEU A 140 | 1.76A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 47GLY B 51VAL B 24LEU B 43LEU B 88 | 1.78A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA B 38GLY B 79GLY B 78SER B 139LEU B 108 | 1.31A | MES B 201 ( 3.4A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127SER B 128LEU B 75HIS B 94 | 1.33A | NoneNoneMES B 201 ( 4.5A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 38GLY A 79GLY A 78LEU A 127SER A 139 | 1.74A | 15.80 | AMP A 201 ( 3.9A)NoneNoneNoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 27GLY A 85LEU A 88LEU A 53HIS A 94 | 1.66A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | SER A 139VAL A 144SER A 166LEU A 160LEU A 12 | 1.73A | 15.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA B 38GLY B 79GLY B 78LEU B 108LEU B 127 | 1.75A | 15.80 | MES B 201 ( 3.4A)NoneNoneNoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | PRO B 125GLY B 85LEU B 53PRO B 32 | 1.79A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY A6890VAL A6865LEU A6893LEU A7052LEU A6924 | 1.61A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 4 | LEU C7010PRO C6860ILE C7080LEU C6961 | 1.63A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6963GLY C6962LEU C7010LEU C7073LEU C6855 | 1.68A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 4 | LEU C7010PRO C6860ILE C7080LEU C6961 | 1.60A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.62A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY A6963GLY A6962LEU A6961LEU A7073LEU A6981 | 1.79A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6962GLY C6963VAL C6865LEU C6855LEU C6887 | 1.79A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY A6890VAL A6865LEU A6893LEU A7052LEU A6924 | 1.58A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6963GLY C6962LEU C7010LEU C7073LEU C6855 | 1.67A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 4 | LEU C6857PRO C6805ILE C7005LEU C6855 | 1.78A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY A6963GLY A6962LEU A7010LEU A7073LEU A6855 | 1.70A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6890VAL C6865LEU C6893LEU C7052LEU C6924 | 1.72A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6962GLY C6963VAL C6965LEU C6857LEU C6924 | 1.75A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY A6962GLY A6963VAL A6965LEU A6857LEU A6924 | 1.77A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | MET A7068LEU A7073GLY A7076LEU A7010 | 1.61A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6890VAL C6865LEU C6893LEU C7052LEU C6924 | 1.69A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY A6962GLY A6963VAL A6965LEU A6857LEU A6924 | 1.76A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY A6963GLY A6962LEU A7010LEU A7073LEU A6855 | 1.69A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6806SER C7041SER C6999LEU C7037LEU C6848 | 1.79A | 15.79 | NoneNoneFMT C7108 ( 2.7A)NoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.59A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | TRP C7029PRO C6810MET C6809LEU C6812 | 1.75A | 15.79 | NoneFMT C7109 ( 4.4A)NoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6962GLY C6963VAL C6965LEU C6857LEU C6924 | 1.75A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6w9q | 3C-LIKE PROTEINASEPEPTIDE, NSP9 FUSION (SARS-CoV-2) | 4 / 8 | PRO A 72LEU A 51GLY A 17LEU A 69 | 1.75A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6w9q | 3C-LIKE PROTEINASEPEPTIDE, NSP9 FUSION (SARS-CoV-2) | 4 / 7 | PRO A 72LEU A 51GLY A 17LEU A 69 | 1.78A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.37A | NoneNoneMES A 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 7 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.78A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.38A | NoneNoneMES A 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 8 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.78A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 38GLY A 79GLY A 78SER A 139LEU A 108 | 1.24A | MES A 201 (-3.6A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.73A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.45A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.46A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 7 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.73A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 38GLY A 79GLY A 78SER A 139LEU A 108 | 1.38A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 38GLY A 79GLY A 78LEU A 108LEU A 127 | 1.64A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 253LEU A 331SER A 332LEU A 279HIS A 298 | 1.31A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 253LEU A 331SER A 332LEU A 279HIS A 298 | 1.34A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU A 59PRO B 121ILE B 106LEU A 56 | 1.37A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU A 59PRO B 121ILE B 106LEU A 56 | 1.47A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 55LEU A 14LEU A 60LEU A 28 | 1.43A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 55SER A 54LEU A 17LEU B 98LEU A 60 | 1.28A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92VAL A 22LEU A 55LEU A 60LEU A 28 | 1.24A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wiq | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.41A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wiq | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.45A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 55LEU A 14LEU A 60LEU A 28 | 1.39A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 6 / 12 | LEU A 55SER A 54LEU A 59LEU A 40MET A 52LEU B 95 | 1.79A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 55SER A 10LEU A 56LEU A 14LEU B 91 | 1.52A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 55SER A 54LEU A 17LEU B 98LEU A 60 | 1.32A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92VAL A 22LEU A 55LEU A 60LEU A 28 | 1.26A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 55SER A 54LEU A 59MET A 52LEU B 95 | 1.53A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU A 339PRO A 309ILE B 320LEU A 353 | 1.72A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU A 353PRO B 309ILE A 337LEU B 331 | 1.55A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU D 353PRO C 309ILE D 337LEU C 331 | 1.62A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU B 353PRO A 309ILE B 337LEU A 331 | 1.62A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA B 264GLY A 316SER A 318LEU B 291LEU B 353 | 1.62A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU B 353PRO A 309ILE B 337LEU A 331 | 1.60A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA A 264GLY B 316SER B 318LEU A 291LEU A 353 | 1.64A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU A 353PRO B 309ILE A 337LEU B 331 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU E 353PRO F 309ILE E 337LEU F 331 | 1.64A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA E 264GLY F 316SER F 318LEU E 291LEU E 353 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA C 264GLY D 316SER D 318LEU C 291LEU C 353 | 1.62A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU C 353PRO D 309ILE C 337LEU D 331 | 1.54A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ALA F 264GLY E 316SER E 318LEU F 291LEU F 353 | 1.65A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU C 353PRO D 309ILE C 337LEU D 331 | 1.56A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU E 339PRO E 309ILE F 320LEU E 353 | 1.78A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU D 353PRO C 309ILE D 337LEU C 331 | 1.64A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU F 353PRO E 309ILE F 337LEU E 331 | 1.65A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU F 353PRO E 309ILE F 337LEU E 331 | 1.66A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 4 | LEU E 353PRO F 309ILE E 337LEU F 331 | 1.66A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.57A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.55A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 4 | LEU C7010PRO C6860ILE C7080LEU C6961 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | TRP C7029PRO C6810MET C6809LEU C6812 | 1.74A | NoneFMT C7105 (-4.6A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | MET A7068LEU A7073GLY A7076LEU A7010 | 1.66A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | TRP A7029PRO A6810MET A6809LEU A6812 | 1.75A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 4 | LEU C7010PRO C6860ILE C7080LEU C6961 | 1.60A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 7 | GLY C 129LYS C 127LEU C 121PRO C 117 | 1.73A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | LEU B 161GLY B 71LEU B 56PRO B 168 | 1.32A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | LEU D 161GLY D 71LEU D 56PRO D 168 | 1.33A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | GLY C 129LYS C 127LEU C 121PRO C 117 | 1.73A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | LEU A 161GLY A 71LEU A 56PRO A 168 | 1.34A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | MET A7068LEU A7073GLY A7076LEU A7010 | 1.61A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | TRP C7029PRO C6810MET C6809LEU C6812 | 1.74A | NoneFMT C7109 ( 4.5A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.61A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 4 | LEU C7010PRO C6860ILE C7080LEU C6961 | 1.59A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 4 | LEU C7010PRO C6860ILE C7080LEU C6961 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.59A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | LEU B 249GLY B 248LEU B 255PRO B 344 | 1.71A | NoneU5P B 401 ( 4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | GLY B 247SER B 288SER B 294LEU B 249LEU B 266 | 1.50A | NoneNoneU5P B 401 (-2.7A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 7 | PRO B 206GLY B 254LYS B 257LEU B 215 | 1.70A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | GLY A 247SER A 288SER A 294LEU A 249LEU A 266 | 1.49A | NoneNoneU5P A 401 (-2.7A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | LEU A 249GLY A 248LEU A 255PRO A 344 | 1.70A | NoneU5P A 401 ( 4.5A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 7 | LEU A 249GLY A 248LEU A 255PRO A 344 | 1.74A | NoneU5P A 401 ( 4.5A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 7 | PRO A 206GLY A 254LYS A 257LEU A 215 | 1.69A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 7 | LEU B 249GLY B 248LEU B 255PRO B 344 | 1.75A | NoneU5P B 401 ( 4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.35A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.34A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA D 38GLY D 79GLY D 78SER D 139LEU D 108 | 1.27A | APR D 201 (-3.2A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL D 49LEU D 127SER D 128LEU D 75HIS D 94 | 1.43A | APR D 201 (-3.6A)NoneAPR D 201 (-4.3A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA B 39GLY B 79GLY B 78LEU B 108LEU B 127 | 1.61A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.38A | APR A 201 (-3.8A)NoneAPR A 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA A 38GLY A 79GLY A 78SER A 139LEU A 108 | 1.25A | APR A 201 (-3.5A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127SER B 128LEU B 75HIS B 94 | 1.45A | APR B 201 (-3.7A)NoneAPR B 201 (-4.5A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127SER C 128LEU C 75HIS C 94 | 1.38A | APR C 201 (-3.8A)NoneAPR C 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA D 39GLY D 79GLY D 78LEU D 108LEU D 127 | 1.61A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | PRO D 125GLY D 85LEU D 53PRO D 32 | 1.79A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA B 38GLY B 79GLY B 78SER B 139LEU B 108 | 1.23A | APR B 201 (-3.3A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | PRO D 125GLY D 85LEU D 53PRO D 32 | 1.78A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.41A | APR A 201 (-3.8A)NoneAPR A 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA A 39GLY A 79GLY A 78LEU A 108LEU A 127 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127SER B 128LEU B 75HIS B 94 | 1.41A | APR B 201 (-3.7A)NoneAPR B 201 (-4.5A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA C 38GLY C 79GLY C 78SER C 139LEU C 108 | 1.25A | APR C 201 (-3.4A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127SER C 128LEU C 75HIS C 94 | 1.36A | APR C 201 (-3.8A)NoneAPR C 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ALA C 39GLY C 79GLY C 78LEU C 108LEU C 127 | 1.60A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.66A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6890VAL A6865LEU A6893LEU A7052LEU A6924 | 1.44A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 4 | LEU A7010PRO A6860ILE A7080LEU A6961 | 1.64A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6890VAL A6865LEU A6893LEU A7052LEU A6924 | 1.49A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | TRP A7029PRO A6810MET A6809LEU A6812 | 1.76A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 17LEU D 98LEU C 60 | 1.18A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 6 / 12 | LEU A 55SER A 54LEU A 59LEU A 40MET A 52LEU B 95 | 1.72A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 55LEU A 14LEU A 60LEU A 28 | 1.44A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU A 59PRO B 121ILE B 106LEU A 56 | 1.55A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92VAL A 22LEU A 55LEU A 60LEU A 28 | 1.22A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 6 / 12 | LEU C 55SER C 54LEU C 59LEU C 40MET C 52LEU D 95 | 1.71A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 55LEU C 14LEU C 60LEU C 28 | 1.48A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 17LEU D 98LEU C 60 | 1.22A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 59MET C 52LEU D 95 | 1.51A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92VAL A 22LEU A 55LEU A 60LEU A 28 | 1.20A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92VAL C 22LEU C 14LEU C 56LEU C 28 | 1.52A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU A 13PRO B 121ILE B 106LEU B 103 | 1.56A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP8 (SARS-CoV-2) | 5 / 12 | GLY D 144VAL D 159SER D 173LEU D 169LEU D 184 | 1.49A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92VAL C 22LEU C 55LEU C 60LEU C 28 | 1.22A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU A 13PRO B 121ILE B 106LEU B 103 | 1.52A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU A 59PRO B 121ILE B 106LEU A 56 | 1.45A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 10LEU C 56LEU C 14LEU D 91 | 1.53A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP8 (SARS-CoV-2) | 5 / 12 | GLY D 144VAL D 159SER D 173LEU D 169LEU D 184 | 1.53A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7 (SARS-CoV-2) | 5 / 12 | VAL A 16LEU A 60SER A 61MET A 62LEU A 20 | 1.52A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 55LEU C 14LEU C 60LEU C 28 | 1.45A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 14SER C 10LEU C 17LEU A 14LEU D 91 | 1.52A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 55SER A 54LEU A 17LEU B 98LEU A 60 | 1.18A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 59PRO D 121ILE D 106LEU C 56 | 1.41A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 14SER C 10LEU C 17LEU A 14LEU D 91 | 1.50A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92VAL C 22LEU C 55LEU C 60LEU C 28 | 1.19A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92VAL A 22LEU A 14LEU A 56LEU A 28 | 1.48A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.44A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 55SER A 54LEU A 17LEU B 98LEU A 60 | 1.22A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 13PRO D 121ILE D 106LEU D 103 | 1.55A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7 (SARS-CoV-2) | 5 / 12 | VAL C 16LEU C 60SER C 61MET C 62LEU C 20 | 1.53A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 55LEU A 14LEU A 60LEU A 28 | 1.47A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.49A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 13PRO D 121ILE D 106LEU D 103 | 1.51A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 55SER A 54LEU A 59MET A 52LEU B 95 | 1.50A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 59PRO D 121ILE D 106LEU C 56 | 1.51A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92VAL A 22LEU A 14LEU A 56LEU A 28 | 1.46A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.39A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.40A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | LEU A 271SER A 267LEU A 272LEU A 282LEU A 205 | 1.77A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 140GLY A 146VAL A 13LEU A 177LEU A 30 | 1.66A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 159GLY A 29VAL A 68SER A 81LEU A 32 | 1.61A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.38A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 23SER A 62LEU A 67LEU A 57LEU A 89 | 1.56A | 14.26 | NoneNoneDMS A 402 ( 4.8A)NoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 159GLY A 146VAL A 20LEU A 27LEU A 32 | 1.73A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 140GLY A 146VAL A 13LEU A 177LEU A 30 | 1.64A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 23SER A 62LEU A 67LEU A 57LEU A 89 | 1.55A | 14.26 | NoneNoneDMS A 402 ( 4.8A)NoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 20LEU A 87LEU A 89LEU A 57LEU A 27 | 1.75A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.39A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | LEU A 268SER A 267LEU A 272LEU A 250HIS A 246 | 1.66A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 159GLY A 29VAL A 68SER A 81LEU A 32 | 1.66A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | LEU A 271SER A 267LEU A 272LEU A 282LEU A 205 | 1.75A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 159GLY A 146VAL A 20LEU A 27LEU A 32 | 1.72A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | LEU A 268SER A 267LEU A 272LEU A 250HIS A 246 | 1.71A | 14.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 6 / 12 | LEU C 55SER C 54LEU C 59LEU C 40MET C 52LEU D 95 | 1.78A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 55LEU C 14LEU C 60LEU C 28 | 1.42A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | GLY A 64LEU A 59LEU A 20LEU A 60LEU A 28 | 1.62A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 4 | LEU C 59PRO D 121ILE D 106LEU C 56 | 1.44A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 4 | LEU C 59PRO D 121ILE D 106LEU C 56 | 1.54A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 4 | LEU C 13PRO D 121ILE D 106LEU D 103 | 1.47A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE D 92VAL C 22LEU C 55LEU C 60LEU C 28 | 1.19A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU A 14SER A 10LEU A 17LEU C 14LEU B 91 | 1.49A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 17LEU D 98LEU C 60 | 1.17A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 4 | LEU A 13PRO B 121ILE B 106LEU B 103 | 1.52A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU C 14SER C 10LEU C 17LEU A 14LEU D 91 | 1.48A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 55LEU A 14LEU A 60LEU A 28 | 1.37A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 55LEU C 14LEU C 60LEU C 28 | 1.45A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE B 92VAL A 22LEU A 14LEU A 56LEU A 28 | 1.52A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE B 92VAL A 22LEU A 55LEU A 60LEU A 28 | 1.13A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE D 92VAL C 22LEU C 55LEU C 60LEU C 28 | 1.16A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 6 / 12 | LEU A 55SER A 54LEU A 59LEU A 40MET A 52LEU B 95 | 1.74A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 4 | LEU A 59PRO B 121ILE B 106LEU A 56 | 1.43A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE B 92VAL A 22LEU A 55LEU A 60LEU A 28 | 1.17A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | VAL A 16LEU A 60SER A 61MET A 62LEU A 20 | 1.53A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.50A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU A 55SER A 54LEU A 59MET A 52LEU B 95 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU A 55SER A 54LEU A 17LEU B 98LEU A 60 | 1.23A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 4 | LEU A 13PRO B 121ILE B 106LEU B 103 | 1.51A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 59MET C 52LEU D 95 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 17LEU D 98LEU C 60 | 1.20A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 10LEU C 56LEU C 14LEU D 91 | 1.56A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 4 | LEU C 13PRO D 121ILE D 106LEU D 103 | 1.49A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | GLY C 64LEU C 59LEU C 20LEU C 60LEU C 28 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 4 | LEU A 59PRO B 121ILE B 106LEU A 56 | 1.36A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 55LEU A 14LEU A 60LEU A 28 | 1.41A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | ALA B 110LEU A 60SER A 61MET A 62LEU A 20 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE D 92VAL C 22LEU C 14LEU C 56LEU C 28 | 1.52A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU A 55SER A 54LEU A 17LEU B 98LEU A 60 | 1.25A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.40A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.40A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 23SER A 62LEU A 67LEU A 57LEU A 89 | 1.51A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.39A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.39A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.38A | NoneEDO A 202 ( 4.8A)EDO A 202 (-4.3A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA C 38GLY C 79GLY C 78SER C 139LEU C 108 | 1.37A | NoneEPE C 202 (-3.4A)NoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | PRO E 125GLY E 85LEU E 53PRO E 32 | 1.79A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA D 39GLY D 79GLY D 78LEU D 108LEU D 127 | 1.64A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127SER C 128LEU C 75HIS C 94 | 1.34A | NoneNoneNoneEPE C 202 (-3.4A)None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA A 38GLY A 79GLY A 78SER A 139LEU A 108 | 1.32A | EDO A 202 (-3.3A)NoneNoneNoneEDO D 202 ( 4.8A) | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.79A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA D 27GLY D 85LEU D 88LEU D 53HIS D 94 | 1.62A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.79A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.41A | NoneEDO A 202 ( 4.8A)EDO A 202 (-4.3A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127SER B 128LEU B 75HIS B 94 | 1.34A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA B 27GLY B 85LEU B 88LEU B 53HIS B 94 | 1.65A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA C 39GLY C 79GLY C 78LEU C 108LEU C 127 | 1.62A | NoneEPE C 202 (-3.4A)NoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 49LEU E 127SER E 128LEU E 75HIS E 94 | 1.35A | NoneNoneEPE E 202 (-4.6A)EPE E 203 (-3.6A)None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA E 38GLY E 79GLY E 78SER E 139LEU E 108 | 1.30A | EPE E 202 (-3.3A)EPE E 203 (-3.3A)NoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL D 49LEU D 127SER D 128LEU D 75HIS D 94 | 1.37A | EDO D 209 (-4.6A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127SER C 128LEU C 75HIS C 94 | 1.37A | NoneNoneNoneEPE C 202 (-3.4A)None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127SER B 128LEU B 75HIS B 94 | 1.38A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 49LEU E 127SER E 128LEU E 75HIS E 94 | 1.33A | NoneNoneEPE E 202 (-4.6A)EPE E 203 (-3.6A)None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA A 27GLY A 85LEU A 88LEU A 53HIS A 94 | 1.64A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA A 39GLY A 79GLY A 78LEU A 108LEU A 127 | 1.62A | NoneNoneNoneEDO D 202 ( 4.8A)EDO A 202 ( 4.8A) | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA C 39GLY C 79GLY C 78LEU C 108LEU C 127 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA E 38GLY E 79GLY E 78SER E 139LEU E 108 | 1.30A | APR E 201 (-3.3A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127SER B 128LEU B 75HIS B 94 | 1.42A | APR B 201 (-3.7A)NoneAPR B 201 (-4.3A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 51GLY B 47VAL E 100SER B 128LEU B 43 | 1.51A | NoneAPR B 201 (-3.6A)NoneAPR B 201 (-4.3A)None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA B 38GLY B 79GLY B 78SER B 139LEU B 108 | 1.34A | APR B 201 (-3.4A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA A 38GLY A 79GLY A 78SER A 139LEU A 108 | 1.33A | APR A 201 (-3.4A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA C 38GLY C 79GLY C 78SER C 139LEU C 108 | 1.33A | APR C 201 (-3.4A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA E 39GLY E 79GLY E 78LEU E 108LEU E 127 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127SER C 128LEU C 75HIS C 94 | 1.41A | APR C 201 (-3.6A)NoneAPR C 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA B 39GLY B 79GLY B 78LEU B 108LEU B 127 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA D 39GLY D 79GLY D 78LEU D 108LEU D 127 | 1.57A | NoneEDO D 203 (-3.1A)NoneEDO A 206 (-4.6A)None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 49LEU E 127SER E 128LEU E 75HIS E 94 | 1.40A | APR E 201 (-3.7A)NoneAPR E 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127SER C 128LEU C 75HIS C 94 | 1.37A | APR C 201 (-3.6A)NoneAPR C 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL D 49LEU D 127SER D 128LEU D 75HIS D 94 | 1.40A | APR D 201 (-3.7A)NoneAPR D 201 (-4.3A)EDO D 202 (-4.6A)None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.43A | APR A 201 (-3.7A)NoneAPR A 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 49LEU E 127SER E 128LEU E 75HIS E 94 | 1.36A | APR E 201 (-3.7A)NoneAPR E 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.40A | APR A 201 (-3.7A)NoneAPR A 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL D 49LEU D 127SER D 128LEU D 75HIS D 94 | 1.43A | APR D 201 (-3.7A)NoneAPR D 201 (-4.3A)EDO D 202 (-4.6A)None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA A 39GLY A 79GLY A 78LEU A 108LEU A 127 | 1.56A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127SER B 128LEU B 75HIS B 94 | 1.39A | APR B 201 (-3.7A)NoneAPR B 201 (-4.3A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA D 38GLY D 79GLY D 78SER D 139LEU D 108 | 1.34A | APR D 201 (-3.3A)EDO D 203 (-3.1A)NoneNoneEDO A 206 (-4.6A) | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA C 27GLY C 85LEU C 88LEU C 53HIS C 94 | 1.65A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA B 38GLY B 79GLY B 78SER B 139LEU B 108 | 1.35A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | PRO B 125GLY B 85LEU B 53PRO B 32 | 1.80A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127SER C 128LEU C 75HIS C 94 | 1.40A | NoneNoneMES C 201 (-4.6A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.80A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA C 38GLY C 79GLY C 78SER C 139LEU C 108 | 1.37A | MES C 201 (-3.5A)NoneNoneNoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.42A | NoneNoneMES A 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127SER C 128LEU C 75HIS C 94 | 1.37A | NoneNoneMES C 201 (-4.6A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127SER B 128LEU B 75HIS B 94 | 1.35A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | PRO B 125GLY B 85LEU B 53PRO B 32 | 1.79A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA A 38GLY A 79GLY A 78SER A 139LEU A 108 | 1.32A | MES A 201 (-3.5A)EDO A 204 (-3.6A)NoneNoneEDO C 205 (-4.9A) | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ALA A 39GLY A 79GLY A 78LEU A 108LEU A 127 | 1.65A | NoneEDO A 204 (-3.6A)NoneEDO C 205 (-4.9A)None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127SER B 128LEU B 75HIS B 94 | 1.38A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 4 | LEU C 127PRO C 32ILE C 23LEU C 153 | 1.78A | NoneNoneEDO C 206 (-4.1A)None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB1283_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | PRO A 125GLY A 85LEU A 53PRO A 32 | 1.79A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127SER A 128LEU A 75HIS A 94 | 1.40A | NoneNoneMES A 201 (-4.4A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.38A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.46A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ALA A 702PHE A 694SER A 784LEU A 786LEU A 247 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7btf | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE A 440LEU C 55SER C 54MET C 52LEU D 95 | 1.53A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 59MET C 52LEU D 103 | 1.55A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 859GLY A 841GLY A 839LEU A 437LEU A 883 | 1.59A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | MET A 380LEU A 401LEU A 673PRO B 121 | 1.16A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7btf | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.69A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 17LEU D 98LEU C 60 | 1.25A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ALA A 866PHE A 859GLY A 841GLY A 839LEU A 883 | 1.60A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7btf | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 59PRO D 121ILE D 106LEU C 56 | 1.51A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | GLY A 841GLY A 839LEU A 437SER C 4LEU C 40 | 1.35A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ALA D 110LEU C 60SER C 61MET C 62LEU C 20 | 1.57A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 469PRO A 461ILE A 632LEU A 630 | 1.60A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7btf | NSP7NSP8 (SARS-CoV-2) | 6 / 12 | SER C 15LEU C 55SER C 54LEU C 59MET C 52LEU D 95 | 1.75A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 469PRO A 461ILE A 632LEU A 630 | 1.50A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ALA A 375SER A 363LEU B 91LEU B 95LEU A 371 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | PRO A 378MET A 380LEU A 673PRO B 121 | 1.48A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | GLY A 841GLY A 839LEU A 437SER C 4LEU C 40 | 1.46A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE A 440LEU C 55SER C 54MET C 52LEU D 95 | 1.36A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 17LEU D 98LEU C 60 | 1.20A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7btf | NSP7 (SARS-CoV-2) | 5 / 12 | VAL C 16LEU C 60SER C 61MET C 62LEU C 20 | 1.51A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92VAL C 22LEU C 55LEU C 60LEU C 28 | 1.42A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7btf | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.34A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.64A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 368VAL A 495SER A 501LEU A 498LEU A 372 | 1.47A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | GLY A 841GLY A 839LEU A 437SER C 4LEU C 40 | 1.47A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92VAL C 22LEU C 55LEU C 60LEU C 28 | 1.41A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | ALA A 443SER C 25LEU C 14SER C 15LEU C 20 | 1.50A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP7 (SARS-CoV-2) | 5 / 12 | GLY C 64LEU C 59LEU C 20LEU C 60LEU C 28 | 1.53A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7btf | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE A 440LEU C 55SER C 54MET C 52LEU D 95 | 1.48A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7btf | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 883PRO A 868ILE A 837LEU A 838 | 1.77A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 368VAL A 495SER A 501LEU A 498LEU A 372 | 1.38A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ALA A 443LEU C 14SER C 10LEU C 17LEU D 91 | 1.43A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7btf | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 59PRO D 121ILE D 106LEU C 56 | 1.40A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 470PRO A 296ILE A 307LEU A 308 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | ALA A 443LEU C 14SER C 15LEU C 55LEU C 59 | 1.62A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 470PRO A 296ILE A 307LEU A 308 | 1.68A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7btf | NSP7 (SARS-CoV-2) | 5 / 12 | VAL C 16LEU C 60SER C 61MET C 62LEU C 20 | 1.53A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | ALA A 423GLY A 841GLY A 839SER C 4LEU C 40 | 0.98A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.39A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 23VAL A 20SER A 62LEU A 57LEU A 89 | 1.31A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 368VAL A 495SER A 501LEU A 498LEU A 372 | 1.43A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 55LEU C 14LEU C 60LEU C 28 | 1.48A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv1 | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.26A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 859GLY A 841GLY A 839LEU A 437LEU A 883 | 1.61A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.73A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.67A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 17LEU D 98LEU C 60 | 1.22A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 59PRO D 121ILE D 106LEU C 56 | 1.39A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 13PRO D 116ILE D 107LEU D 103 | 1.79A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv1 | NSP7 (SARS-CoV-2) | 5 / 12 | GLY C 64LEU C 59LEU C 20LEU C 60LEU C 28 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ALA D 110LEU C 60SER C 61MET C 62LEU C 17 | 1.42A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | PRO A 243MET A 242LEU A 247LEU A 131 | 1.70A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv1 | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.21A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 59MET C 52LEU D 95 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 470PRO A 296ILE A 307LEU A 308 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 59MET C 52LEU D 103 | 1.53A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv1 | NSP7 (SARS-CoV-2) | 5 / 12 | LEU C 60SER C 61LEU C 56MET C 62LEU C 17 | 1.50A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | MET A 380LEU A 401LEU A 673PRO B 121 | 1.13A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 469PRO A 461ILE A 632LEU A 630 | 1.65A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | PRO A 627MET A 626LEU A 460PRO A 677 | 1.70A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv1 | NSP7 (SARS-CoV-2) | 5 / 12 | VAL C 16LEU C 60SER C 61MET C 62LEU C 20 | 1.37A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv1 | NSP7 (SARS-CoV-2) | 6 / 12 | GLY C 64VAL C 22LEU C 59SER C 57LEU C 17LEU C 28 | 1.77A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92VAL C 22LEU C 55LEU C 60LEU C 28 | 1.32A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 55LEU C 14LEU C 60LEU C 28 | 1.51A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 13PRO D 116ILE D 107LEU D 103 | 1.76A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.68A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv1 | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE A 415LEU C 55LEU C 59MET C 52LEU D 103 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 469PRO A 461ILE A 632LEU A 630 | 1.72A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | PRO A 378MET A 380LEU A 673PRO B 121 | 1.47A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | LEU C 55SER C 54LEU C 17LEU D 98LEU C 60 | 1.25A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92VAL C 22LEU C 55LEU C 60LEU C 28 | 1.30A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | PRO A 243MET A 242GLY A 179LEU A 131 | 1.54A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 470PRO A 296ILE A 307LEU A 308 | 1.68A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 368VAL A 495SER A 501LEU A 498LEU A 372 | 1.34A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ALA D 110LEU C 60SER C 61MET C 62LEU C 20 | 1.46A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv1 | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ALA A 443LEU C 14SER C 10LEU C 17LEU D 91 | 1.44A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 4 / 4 | LEU C 59PRO D 121ILE D 106LEU C 56 | 1.44A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | PRO A 243MET A 463LEU A 247LEU A 131 | 1.80A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | GLY A 841GLY A 839LEU A 437SER C 4LEU C 40 | 1.50A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 470PRO A 296ILE A 307LEU A 308 | 1.71A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 6 / 12 | PHE A 407GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.71A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv2 | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 186SER B 173LEU B 169LEU B 184 | 1.48A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 368VAL A 495SER A 501LEU A 498LEU A 372 | 1.44A | NoneNone U T 9 ( 2.7A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 368VAL A 495SER A 501LEU A 498LEU A 372 | 1.44A | NoneNone U T 9 ( 2.7A)NoneNone | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | PRO A 378MET A 380LEU A 673PRO B 121 | 1.54A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | GLY A 841GLY A 839LEU A 437SER C 4LEU C 40 | 1.49A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | GLY A 670GLY A 671LEU A 388LEU A 401MET B 129 | 1.49A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 441GLY A 839GLY A 841LEU A 862SER A 861 | 1.48A | NoneNoneNone U P 17 ( 4.9A) U P 17 ( 3.7A) | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ALA A 185GLY A 179LEU A 178LEU A 241LEU A 131 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ALA A 866PHE A 859GLY A 841GLY A 839LEU A 883 | 1.65A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA11_1 (CES1 PROTEIN) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | MET A 380LEU A 401LEU A 673PRO B 121 | 1.20A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv2 | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.31A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 883PRO A 868ILE A 837LEU A 838 | 1.78A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv2 | NSP7 (SARS-CoV-2) | 5 / 12 | VAL C 16LEU C 60SER C 61MET C 62LEU C 20 | 1.39A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 883PRO A 868ILE A 837LEU A 838 | 1.72A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 469PRO A 461ILE A 632LEU A 630 | 1.63A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 469PRO A 461ILE A 632LEU A 630 | 1.70A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv2 | NSP7 (SARS-CoV-2) | 5 / 12 | LEU C 60SER C 61LEU C 56MET C 62LEU C 17 | 1.44A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_2 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 4 | LEU A 470PRO A 296ILE A 307LEU A 308 | 1.60A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ALA A 702PHE A 694SER A 784LEU A 786LEU A 247 | 1.58A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_2 (CES1 PROTEIN) | 7bv2 | NSP8 (SARS-CoV-2) | 4 / 4 | LEU B 98PRO B 116ILE B 107LEU B 103 | 1.45A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) | 7bv2 | NSP8 (SARS-CoV-2) | 5 / 12 | GLY B 144VAL B 159SER B 173LEU B 169LEU B 184 | 1.44A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 441GLY A 839GLY A 841LEU A 862SER A 861 | 1.56A | NoneNoneNone U P 17 ( 4.9A) U P 17 ( 3.7A) | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_A_CTXA1_1 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 859GLY A 841GLY A 839LEU A 437LEU A 883 | 1.62A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_B_CTXB2_1 (CES1 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 441GLY A 839GLY A 841LEU A 862SER A 861 | 1.51A | NoneNoneNone U P 17 ( 4.9A) U P 17 ( 3.7A) |